Stonepine Capital Management »

Surrozen shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $724k 66k 10.95

More positions owned by Stonepine Capital Management

Adma Biologics (ADMA)
Alimera Sciences Com New
Evolus (EOLS)
Galapagos Nv- Spons Adr (GLPG)
Revance Therapeutics (RVNC)
Xoma Corp Com New (XOMA)
Anika Therapeutics (ANIK)
Tela Bio (TELA)
Rigel Pharmaceuticals Com New (RIGL)
Optinose (OPTN)
Aclaris Therapeutics (ACRS)
Scpharmaceuticals (SCPH)
Aurinia Pharmaceuticals (AUPH)
Milestone Pharmaceuticals (MIST)
Aytu Biopharma (AYTU)

View all positions for Stonepine Capital Management

Top funds holding Surrozen

RA Capital Management
Alyeska Investment Group
Armistice Capital
Nantahala Capital Management
Stempoint Capital
Euclidean Capital
Stonepine Capital Management
CVI Holdings
Vanguard Group
Arrowpoint Asset Management
Board of Trustees of The Leland Stanford Junior University
Morgan Stanley
Geode Capital Management
Renaissance Technologies
BlackRock

View all funds holding Surrozen